Tixagevimab/Cilgavimab Treatment and Cardiovascular Events: Immortal time bias

AlexandrosSfakianakis shared this article with you from Inoreader Tixagevimab/Cilgavimab Treatment and Cardiovascular Events: Immortal time bias via Clinical Infectious Diseases Advance Access View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.